Abemaciclib is a chemotherapy drug used to treat breast cancer. It is a type of drug called a cyclin-dependent kinase (CDK) inhibitor. Abemaciclib works by blocking two enzymes (CDK4 and CDK6) that help tumor cells grow and divide. This stops the tumor cells from growing and dividing, which can slow down or stop the growth of the tumor. Abemaciclib is used in combination with other medications to treat breast cancer that has spread to other parts of the body (metastatic breast cancer).
Abemaciclib, sold under the brand name Lynparza, is a medication classified as a cyclin-dependent kinase (CDK) inhibitor. It is primarily used to treat certain types of breast cancer in women. Here's a breakdown of its key points:
Type of drug:
- Targeted therapy: Abemaciclib targets specific molecules involved in the growth and survival of cancer cells, offering a more precise approach to cancer treatment compared to traditional chemotherapy.
Conditions treated:
- Metastatic breast cancer: Abemaciclib is approved for the treatment of hormone receptor (HR)-positive, HER2-negative, locally advanced or metastatic breast cancer in postmenopausal women who have received prior hormonal therapy, either as adjuvant therapy (after surgery) or for advanced/metastatic disease.
- Lobular breast cancer: Abemaciclib is also indicated for the treatment of high-risk early-stage HR-positive, HER2-negative, node-positive lobular breast cancer in postmenopausal women following completion of adjuvant hormonal therapy.
Mechanism of action:
- Abemaciclib works by inhibiting cyclin-dependent kinases (CDKs), which are enzymes essential for cell division. By blocking CDKs, Abemaciclib disrupts the uncontrolled growth and spread of cancer cells.
Important to note:
- Abemaciclib is typically administered orally as a tablet, taken once daily with or without food.
- It is often used in combination with other medications, such as an aromatase inhibitor (AI) like letrozole or anastrozole, to enhance its effectiveness in treating hormone receptor-positive breast cancer.
- Abemaciclib does not cure cancer but can help slow or stop the growth of cancer cells and improve survival outcomes in patients with specific types of breast cancer.
- Like any medication, Abemaciclib can cause side effects, including diarrhea, fatigue, nausea, and decreased white blood cell count. It is crucial to discuss the potential risks and benefits with your doctor before starting treatment.
Disclaimer: This information is for general knowledge purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for diagnosis, treatment, and personalized recommendations.